Drugs & TargetsFree Breakthrough Therapy Granted to Boehringer Ingelheim TKI Inhibitor in NSCLC January 08, 2016Vol.42 No.01
Drugs & TargetsFree Amgen enters into agreement with GSK to reclaim rights to Prolia, XGEVA, and Vectibix January 08, 2016Vol.42 No.01
Drugs & TargetsFree Stem Cell Theranostics and CapellaBio launch collaboration on cardiotoxicity January 08, 2016Vol.42 No.01
Drugs & Targets FDA Approves Opdivo Injection for Renal Cell Carcinoma Patients December 25, 2015Vol.38 No.12
Drugs & TargetsFree Amgen enters into agreement with GSK to reclaim rights to Prolia, XGEVA, and Vectibix December 18, 2015Vol.41 No.46
Drugs & TargetsFree Stem Cell Theranostics and CapellaBio launch collaboration on cardiotoxicity December 18, 2015Vol.41 No.46
Drugs & Targets Amgen submits expanded application for Kyprolis in the EU December 11, 2015Vol.41 No.45
Drugs & Targets FDA clears cooling cap for preventing hair loss during chemotherapy December 11, 2015Vol.41 No.45
